HealthQuill Cancer DNA Modification
Modifi Biosciences, Inc., a Yale University spinout company formed in 2021, has been acquired by Merck & Co. for about $1.3 billion to gain access to therapies that aim to kill cancer cells by modifying cancer DNA selectively.
Drugs Health Pharma

Merck acquires Yale University spinout Modifi Biosciences for up to $1.3 billion

Modifi Biosciences, Inc., a Yale University spinout company formed in 2021, has been acquired by Merck & Co. for about $1.3 billion to.

Read More